Prof. Dr. İnci YILDIZ

Yayın Ağı

Makaleler 33

1. Febrile neutropenia in children with acute lymphoblastic leukemia: single center experience

Ozdemir N., Tuysuz G., Celik N., Yantri L., Erginoz E., Apak H., et al.

TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , cilt.51, sa.2, ss.79-86, 2016 (ESCI)

2. The Role of Epstein-Barr Virus LMP-1 Immunohistochemical Staining in Childhood Hodgkin Lymphoma

Tanyildiz H. G., Yildiz I., Bassullu N., Tuzuner N., Ozkan A., Celkan T., et al.

IRANIAN JOURNAL OF PEDIATRICS , cilt.25, sa.6, 2015 (SCI-Expanded)

3. LANGERHANS CELL HISTIOCYTOSIS: ONE CENTER EXPERIENCE

Ozdemir N., Celkan T., Tuysuz G., Apak H., Adaletli I., Hallac M., et al.

PEDIATRIC BLOOD & CANCER , cilt.62, 2015 (SCI-Expanded)

4. Initial Management of Childhood Acute Immune Thrombocytopenia: Single-Center Experience of 32 Years

Yildiz I., Ozdemir N., Celkan T., Soylu S., Karaman S., Canbolat A., et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.32, sa.6, ss.406-414, 2015 (SCI-Expanded)

5. POLYMORPHISM IN TLR2, TLR4 AND SUSCEPTIBILITY TO FEBRILE NEUTROPENIA AND FUNGAL INFECTIONS IN CHILDREN WITH LEUKEMIA

Ozdemir N., Celkan T., Guven M., Batar B., Tuysuz G., Apak H., et al.

PEDIATRIC BLOOD & CANCER , cilt.57, sa.5, ss.848, 2011 (SCI-Expanded)

6. PRIMARY GASTROINTESTINAL NON-HODGKIN LYMPHOMA IN A RENAL TRANSPLANT RECIPIENT CHILD

Celkan T., Ozdemir N., Sever L., Caliskan S., Elicevik M., Aki H., et al.

PEDIATRIC BLOOD & CANCER , cilt.57, sa.5, ss.874, 2011 (SCI-Expanded)

7. THE TURKISH PEDIATRIC ONCOLOGY GROUP NEUROBLASTOMA 2003 (TPOG-NBL-2003) PROTOCOL: FACTORS THAT EFFECT SURVIVAL RATES

İNCE D., Aksoylar S., Varan A., Vergin C., Hazar V., Sevinir B., et al.

PEDIATRIC BLOOD & CANCER , cilt.57, sa.5, ss.795, 2011 (SCI-Expanded)

8. THE ASSOCIATION OF TOLL-LIKE 4 (TLR-4) AND NOD2 POLYMORPHISMS AND FEBRILE NEUTROPENIA IN CHILDREN WITH BURKITT LYMPHOMA

Ozdemir N., Guven M., Batar B., Apak H., Tuysuz G., BARIŞ S., et al.

PEDIATRIC BLOOD & CANCER , cilt.57, sa.5, ss.844, 2011 (SCI-Expanded)

9. DECTIN-1 AND NOD2 POLYMORPHISMS AND SUSCEPTIBILITY TO INFECTIONS, RELAPSE AND OTHER COMPLICATIONS IN CHILDREN WITH ACUTE LYMPHOBLASTIC LEUKEMIA

Celkan T., Guven M., Ozdemir N., Batar B., Tuysuz G., Apak H., et al.

PEDIATRIC BLOOD & CANCER , cilt.57, sa.5, ss.874, 2011 (SCI-Expanded)

10. Novel Influenza a (H1N1) Infection in a Pediatric Hematology Oncology Clinic During the 2009-2010 Pandemia

Ozdemir N., Celkan T., Midilli K., Aygun G., Sinekbasan S., Kilic O., et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.28, sa.4, ss.288-293, 2011 (SCI-Expanded) Sürdürülebilir Kalkınma

11. THE TURKISH PEDIATRIC ONCOLOGY GROUP NEUROBLASTOMA 2003 (TPOG-NBL-2003):TREATMENT RESULTS OF THE INFANTS

İNCE D., Aksoylar S., Buyukpamukcu M., Varan A., Hazar V., Vergin C., et al.

PEDIATRIC BLOOD & CANCER , cilt.55, sa.5, ss.890, 2010 (SCI-Expanded)

12. TREATMENT OF WILMS TUMOR: A Report from the Turkish Pediatric Oncology Group (TPOG)

AKYÜZ C., YALÇIN B., Yildiz I., Hazar V., Yoruk A., Tokuc G., et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.27, sa.3, ss.161-178, 2010 (SCI-Expanded) Sürdürülebilir Kalkınma

13. CLINICAL FEATURES OF ACUTE LYMPHOBLASTIC LEUKEMIA IN TURKISH CHILDREN (RESULTS FROM A SINGLE CENTER)

Yildiz I., Dogru O., Ozbek U., Ozdemir G. N., Celkan T., Apak H., et al.

PEDIATRIC BLOOD & CANCER , cilt.53, sa.5, ss.773, 2009 (SCI-Expanded)

14. THE PROGNOSTIC SIGNIFICANCE OF GENETIC, IMMUNOPHENOTYPIC AND CLINICAL FEATURES OF ACUTE LYMPHOBLASTIC LEUKEMIA IN TURKISH CHILDREN (RESULTS FROM A SINGLE CENTER)

Yildiz I., Dogru O., Ozbek U., Celkan T., Apak H., Ozkan A., et al.

PEDIATRIC BLOOD & CANCER , cilt.53, sa.5, ss.767, 2009 (SCI-Expanded)

15. Iron deficiency anemia

Yildiz I.

TURK PEDIATRI ARSIVI-TURKISH ARCHIVES OF PEDIATRICS , cilt.44, ss.14-18, 2009 (SCI-Expanded)

16. DNA repair gene XPD and XRCC1 polymorphisms and the risk of childhood acute lymphoblastic leukemia

Batar B., Guven M., Baris S., Celkan T., Yildiz I.

LEUKEMIA RESEARCH , cilt.33, sa.6, ss.759-763, 2009 (SCI-Expanded) Sürdürülebilir Kalkınma

17. Prognostic factors in children with Hodgkin disease

Celkan T., Yildiz I.

PEDIATRIC BLOOD & CANCER , cilt.51, sa.5, ss.712, 2008 (SCI-Expanded)

18. Is Familial Mediterranean Fever a thrombotic disease or not?

Demirel A., Celkan T., Kasapcopur O., Bilgen H., Ozkan A., Apak H., et al.

EUROPEAN JOURNAL OF PEDIATRICS , cilt.167, sa.3, ss.279-285, 2008 (SCI-Expanded)

19. Late effects of chyldhood all treatment on body mass yndex and serum leptyn levels

Yildiz I., Karaman S., Ercan O., Celkan T., Apak H., Ozkan A.

PEDIATRIC BLOOD & CANCER , cilt.49, sa.4, ss.547, 2007 (SCI-Expanded)

20. Turkish Pediatric Oncology Group (TPOG) Wilms tumor study: Preoperative treatment results

Akvuz C., Yalcin B., Olgun N., Buyukpamukcu N., Caglar M., Atahan I. L., et al.

PEDIATRIC BLOOD & CANCER , cilt.49, sa.4, ss.457, 2007 (SCI-Expanded)

21. Coping style, depression, anxiety, and posttraumatic stress during first six months after diagnosis in mothers of children with cancer in Turkey

Temiz E., Apak H., Yildiz I., Boman K.

PEDIATRIC BLOOD & CANCER , cilt.49, sa.4, ss.544, 2007 (SCI-Expanded) Sürdürülebilir Kalkınma

22. Osteosarcoma: Review of 107 cases

Kepil N., Bagci P., Dervisoglu S., Colpan D., Dincbas F., Mande N. M., et al.

VIRCHOWS ARCHIV , cilt.451, sa.2, ss.569, 2007 (SCI-Expanded)

23. Retinoblastoma in Turkey: survival and clinical characteristics 1981-2004

Ozkan A., Pazarli H., Celkan T., Karaman S., Apak H., Kaner G., et al.

PEDIATRICS INTERNATIONAL , cilt.48, sa.4, ss.369-373, 2006 (SCI-Expanded)

24. Antiviral prophylaxis with continuous low dose acyclovir in childhood cancer

Celkan T. T., OZKAN A., Apak H., YILDIZ I.

LEUKEMIA & LYMPHOMA , cilt.47, sa.7, ss.1418-1420, 2006 (SCI-Expanded) Sürdürülebilir Kalkınma

25. Common cytochrome p4503A (CYP3A4 and CYP3A5) and thiopurine S-methyl transferase (TPMT) polymorphisms in Turkish population

Aydin Sayitoǧlu M., Yildiz I., Hatirnaz Ö., Özbek U.

Turkish Journal of Medical Sciences , cilt.36, sa.1, ss.11-15, 2006 (SCI-Expanded)

26. Late effects of childhood acute lymphoblastic leukemia treatment on body mass index and serum leptin levels

Karaman S., Ercan O., Yildiz I., Celkan T., Apak H., Ozkan A.

HORMONE RESEARCH , cilt.65, ss.123-124, 2006 (SCI-Expanded)

27. The anemia of familial Mediterranean fever disease

Celkan T. T., CELIK M., KASAPCOPUR O., OZKAN A., APAK H., OCAK S., et al.

PEDIATRIC HEMATOLOGY AND ONCOLOGY , cilt.22, sa.8, ss.657-665, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

28. Antibody titers and immune response to diphtheria-tetanus-pertussis and measles-mumps-rubelia vaccination in children treated for acute lymphoblastic leukemia

ERCAN T., SOYCAN L., APAK H., Celkan T. T., OZKAN A., AKDENIZLI E., et al.

JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY , cilt.27, sa.5, ss.273-277, 2005 (SCI-Expanded) Sürdürülebilir Kalkınma

29. Wilms Kemoterapisi ve Asit

KARAMAN S., CELKAN T. T., KURUĞOĞLU S., CANPOLAT A., KIYKIM E., ÖZKAN M. A., et al.

Turkish Journal of Oncology , cilt.20, sa.2, ss.79-83, 2005 (Hakemli Dergi)

30. NAD(P)H : quinone oxidoreductase 1 null genotype is not associated with pediatric de novo acute leukemia

SIRMA S. Ö., AGAOGLU L., YILDIZ i., CAYLI D., HORGUSLUOGLU L., ANAK S. S., et al.

PEDIATRIC BLOOD & CANCER , cilt.43, sa.5, ss.568-570, 2004 (SCI-Expanded, Scopus)

31. Blue rubber bleb nevus syndrome associated with consumption coagulopathy: treatment with interferon

APAK H., Celkan T. T., OZKAN A., YILDIZ i., AYDEMIR E., OZDIL S., et al.

DERMATOLOGY , cilt.208, sa.4, ss.345-348, 2004 (SCI-Expanded)

32. Severe factor X deficiency treated with heparin-added prothrombin complex concentrate

APAK H., Celkan T. T., OZKAN A., YUKSEL L., BILGI Z., YILDIZ i.

ANNALS OF HEMATOLOGY , cilt.82, sa.11, ss.710-711, 2003 (SCI-Expanded)

33. Toxic epidermal necrolysis after the use of high-dose cytosine arabinoside

OZKAN A., APAK H., Celkan T. T., YUKSEL L., YILDIZ i.

PEDIATRIC DERMATOLOGY , cilt.18, sa.1, ss.38-40, 2001 (SCI-Expanded)

Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler 3

1. Febrile Neutropenia in Children with Acute Lymphoblastic Leukemia Treated with BFM Protocols

Ozdemir G. N., Tuysuz G., Apak H., Ozkan A., Yildiz I., Celkan T.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

2. Hodgkin's Disease (1975-2012): Long-Term Results of a Single Center

Celkan T., Ozdemir G. N., Aki H., Apak H., Ozkan A., Hallac M., et al.

56th Annual Meeting of the American-Society-of-Hematology, San-Francisco, Kostarika, 6 - 09 Aralık 2014, cilt.124, (Özet Bildiri)

3. Translokasyon (8;21) ve Ek Kromozom Anomalileri Gözlenen Akut Myeloid Lösemili Olgular.

ÇIRAKOĞLU A., KURU R. D., SAĞCI GÜVEN G., TARKAN ARGÜDEN Y., YILMAZ Ş., YILDIZ İ., et al.

VII.Ulusal Prenatal Tanı Ve Tıbbi Genetik Kongresi, Kayseri, Türkiye, ss.182, (Tam Metin Bildiri)

Metrikler

Yayın

Yayın (WoS)

Yayın (Scopus)

Atıf (WoS)

282

H-İndeks (WoS)

Atıf (Scopus)

333

H-İndeks (Scopus)

Proje

BM Sürdürülebilir Kalkınma Amaçları

Yayınlar & Eserler